| DC Field | Value | Language |
|---|
| dc.contributor.author | Upcott, M. | - |
| dc.contributor.author | Chaprov, K. D. | - |
| dc.contributor.author | Buchman, V. L. | - |
| dc.date.accessioned | 2025-04-18T14:05:32Z | - |
| dc.date.available | 2025-04-18T14:05:32Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.citation | Upcott, M. Toward a disease-modifying therapy of alpha-synucleinopathies: new molecules and new approaches came into the limelight / M. Upcott, K.D. Chaprov, V.L. Buchman // Molecules. - 2021. - Vol.26, №23.-Art. 7351. - Doi: 10.3390/molecules26237351. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/64888 | - |
| dc.description.abstract | The principal aim of this review is to critically evaluate the potential of therapeutic strategies that target the post-transcriptional steps of alpha-synuclein production and immunotherapy-based approaches to alpha-synuclein degradation in PD/DLB patients | ru |
| dc.language.iso | en | ru |
| dc.subject | biology | ru |
| dc.subject | biochemistry | ru |
| dc.subject | alpha-synuclein | ru |
| dc.subject | biomarkers | ru |
| dc.subject | rodent models | ru |
| dc.subject | Parkinson’s disease | ru |
| dc.subject | translational research | ru |
| dc.title | Toward a disease-modifying therapy of alpha-synucleinopathies: new molecules and new approaches came into the limelight | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
